Effects of photodynamic therapy in combination with Adriamycin

Cancer Letters

Volumn 146, Issue 1, 1999, Pages 73-86

  Streckyte, G ^a   Didziapetriene, J ^b   Grazeliene, G ^b   Prasmickiene, G ^b   Sukeliene, D ^b   Kazlauskaite, N ^b   Characiejus, D ^b   Griciute, L ^b   Rotomskis, R ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Lithuanian Oncology Cent   (Lithuania)

Author keywords

Adriamycin; Combination therapy; Lipid peroxidation; Malondialdhyde; Photodynamic therapy

Indexed keywords

DOXORUBICIN; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; LUNG CARCINOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DNA, NEOPLASM; DOXORUBICIN; HEMATOPORPHYRIN PHOTORADIATION; MALONDIALDEHYDE; MICE; NEOPLASMS, EXPERIMENTAL; PHOTOSENSITIZING AGENTS;

EID: 0032844950     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00241-4     Document Type: Article

References (46)

1. Dougherty T.J., Potter W.R., Belliner D. Photodynamic therapy for the treatment of cancer: current status and advances. Kessel D. Photodynamic Therapy of Neoplastic Disease. 1990;1-19 CRC Press, Boca Raton FL.
2. Henderson B. Photodynamic therapy - coming of age. Photodermatology. 6:1990;200-211.
3. Hayata Y., Kato H. Photodynamic therapy in treatment of early cancer. Henderson B.W., Dougherty T.J. Photodynamic Therapy: Basic Principle and Clinical Application. 1992;269-278 Marcel Dekker Inc, New York.
4. Henderson B.W., Waldow S.M., Mang T.S, Dougherty T.J. Photodynamic therapy and hyperthermia. Jori G., Perria C. Photodynamic Therapy of Tumours and Other Diseases. 1985;183-193 Libreria Progetto Editore, Padua.
5. Ma L.W., Iani V., Moan J. Combination therapy: photochemotherapy, electric current, and ionizing radiation. Different combinations studied in a WiDr human colon adenocarcinoma cell line. J. Photochem. Photobiol. B. Biol. 21:1993;149-154.
6. Cowled P.A., Mackenzie I., Forbes I.J. Interaction between photochemotherapy with HPD and light and cytotoxic drugs. Aust. N.Z. J. Med. 15:1985;127-131.
7. Cowled P.A., Mackenzie I., Forbes I.J. Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light. Cancer Res. 47:1987;971-974.
8. Edell E.S., Cortese D.A. Combined effects of hematoporphyrin derivative phototherapy and adriamycin in a murine tumor mode. Lasers Surg. Med. 8:1988;413-417.
9. Ma L.W., Berg K., Danielsen H.E., Kaalhus O., Iani V., Moan J. Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors. Cancer Lett. 109:1996;129-139.
10. Cho Y.H., Straight R.C., Smith J.A. Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model. J. Urol. 147:1992;743-746.
11. DiMarco A. Adriamycin (NSC 123127): mode and mechanism of action. Cancer Chemother. Rep. 6:1975;91-106.
12. Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J.M. Evidence of a specific complex between Adriamycin and negatively charged phospholipids. Biochim. Biophys. Acta. 597:1980;1-14.
13. Bachur N.R., Gordon S.L., Gee M.V. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol. Pharmacol. 13:1977;901-910.
14. Peterson C.M., Lu J.M., Gu Z.W., Shiah J.G., Lythogoe K., Peterson C.A., Straight R.C., Kopecek J. Isobolographic assessment of the interaction between Adriamycin and meso-chlorin e6 monoethylene diamine in human ovarian epithelial carcinoma (OVARCAR-3) in vitro. J. Soc. Gynecol. Invest. 2:1995;772-777.
15. Brophy P.F., Keller S.M. Adriamycin enhaced in vitro and in vivo photodynamic therapy of mesothelioma. J. Surg. Res. 52:1992;631-634.
16. Berns M.W., Dahlman A., Johanson F.M., Burns R., Sperling D., Guiltinam M., Siemans A., Walter R., Wright W., Hammerwilson M., Wile A. In vitro cellular effects of hematoporphyrin derivative. Cancer Res. 42:1982;2325-2329.
17. Dorr R.T., Alberts D.S. Pharmacology of doxorubicin. Jones S.E. Current Concepts in the Use of Doxorubicin Chemotherapy. 1982;3-20 Farmitalia Carlo Erbi S.p.A, Milan.
18. Handa K., Sato S. Generation of free radicals of quinone group containing anticancer chemicals in NADPH-microsound system as evidenced by initiation of sulfite oxidation. Gann. 66:1975;43-47.
19. Moan J., Pettersen E.O., Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of hematoporphyrin. Br. J. Cancer. 39:1979;398-407.
20. Evensen J.F., Moan J. Photodynamic therapy of C3H tumours in mice: effect of drug/light dose fractionation and misonidazole. Lasers Med. Sci. 3:1988;1-6.
21. Casas A., Fukuda H., Riley P., Batlle A. Enhancement of aminolevulinic acid based photodynamic therapy by Adriamycin. Cancer Lett. 121:1997;105-113.
22. Streckyte G., Bagdonas S., Rotomskis R. Spectroscopic investigations of the interaction between photosensitizer and antitumour drug. Lith. J. Phys. 38:1998;71-74.
23. Onkawa H., Ohishi N., Yasi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
24. Girotti A.W. Mechanism of lipid peroxidation. J. Free Radicals Biol. Med. 1:1985;87-95.
25. Faber M., Coundray C., Hida H., Mousseau M., Farer A. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherpy, including adriamycin. Biol. Trace Elem. Res. 47:1995;117-123.
26. Look M.P., Musch E. Lipid peroxides in the polichemotherapy of cancer patients. Chemotherapy. 41:1994;8-15.
27. Weishoupt K.R., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 36:1976;2326-2329.
28. Torinuki W., Miura T., Seiji M. Lysosome destruction and lipoperoxide formation due to active oxygen generated from haematoporphyrin and UV irradiation. Br. J. Dermatol. 102:1980;17-27.
29. Thomas J.P., Girotti A.W. Photooxidation of cell membranes in the presence of hematoporphyrin derivative: reactivity of phospholipid and cholesterol hydroperoxides with glutathione peroxidase. Biochim. Biophys. Acta. 962:1988;297.
30. Girotti A.W. Photosensitized lipid peroxidation in biological membranes. Kessel D. Photodynamic Therapy of Neoplastic Disease 1. 1990;229-245 CRC Press, Boca Raton, FL.
31. Prasmickaite L., Kirveliene V., Kadziauskas J., Juodka B., Didziapetriene J. Photosensitized lipid peroxidation in MH-22 cells in vitro and in vivo. Biologija. 1-2:1995;109-110.
32. Perret C., Foultier M.T., Vonarx-Coinsman V., Quancard O., Combre A., Patrice T. Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative. J. Pharmacol. Exp. Ther. 269:1994;787-791.
33. Juzenas P., Didziapetriene J., Staciokiene L., Gudelis V., Slavenas J., Rotomskis R. Photomodifications of photodrugs in tumours. Ehrenberg B., Jori G., Moan J. Photochemotherapy: Photodynamic Therapy and Other Modalities. 1996;499-506 Procceedings of SPIE 2625.
34. Alfano R.R., Tata D.B., Cordero J., Tomashefsky P., Longo F.W., Alfano M.A. Laser induced fluorescence spectroscopy from native and normal tissue. IEEE J. Quantum Electronics. 20:1984;1507-1511.
35. Smaliukiene Z., Didziapetriene J., Staciokiene L. Influence of photosensitizers photosan and chlorin e6 on hemopoiesis in experimental studies. Acta Medica Lituanica. 4:1997;25-30.
36. Martini A., Donelli M.G., Mantovani A., Pacciarini M.A., Fogar-Ottavoano E., Morasca L., Garattini S., Spreafico F. Antineoplastic activity and pharmacokinetics of adriamycin and daunomycin in tumour bearing mice. Oncology. 34:1977;173-178.
37. Revis N., Marusic N. Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits. J. Mol. Cell Card. 10:1978;945-951.
38. Llesuy S., Arnaiz S. Hepatotoxicity of mitoxantrone and doxorubicin. Toxicology. 63:1990;187-198.
39. Nahabedian M.Y., Cohen R.A., Contino M.F., Terem T.M., Wright W.H., Berns M.W., Wile A.G. Combination cytotoxic chemotherapy with cisplastin or doxorubicin and photodynamic therapy in murine tumours. J. Natl. Cancer Inst. 80:1988;739-743.
40. Jori G. Photosensitized process in vivo: proposed phototherapeutic applications. Photochem. Photobiol. 52:1990;439-443.
41. Moan J., Rimington C., Western A. The binding of dihematoporphyrin ether (photofrin II) to human serum albumin. Clinica Chimica Acta. 145:1985;227-236.
42. Jasaiti A. Jr, Streckyte G., Rotomskis R. Photophysics of sensitizer-protein complexes. Lith. J. Phys. 36:1996;302-399.
43. Rotomskis R., Streckyte G., Bagdonas S. Phototransformations of sensitizers 1. Significance of the nature of the sensitizer in the photobleaching process and photoproduct formation in aqueous solution. J. Photochem. Photobiol. B. Biol. 39:1997;167-171.
44. Streckyte G., Bagdonas S., Rotomskis R. Interaction between photosensitizer, chemotherapeutic drug and HSA: implications for photodynamic therapy. Ehrehberg B., Berg K. Photochemotherapy of Cancer and Other Diseases. 1999;137-142 Proceedings of SPIE 3563.
45. Rotomskis R., Bagdonas S., Streckyte G., Wendenberg R., Dietel W., Didziapetriene J., Ibelhauptaite A., Staciokiene L. Phototransformations of sensitizers: 3. Implications for clinical dosimetry. Lasers Med. Sci. 13:1998;271-278.
46. Streckyte G., Didziapetriene J., Jonuska A., Rotomskis R. Photophysical aspects of combined therapy. Medicina. 35:1999;105-113.